If you or a loved one were seriously injured by a drug containing metoclopramide, such as Reglan Oral Disintegrating Tablets, Metoclopramide Oral Solution, or Reglan Injection, you may be entitled to file a Reglan lawsuit. A Reglan lawsuit seeks compensation for medical bills, pain and suffering, lost wages, and other injuries.

Reglan Tardive Dyskinesia

High doses and/or long term use of Reglan may lead to a drug-induced movement disorder known as tardive dyskinesia. Tardive means “delayed and dyskinesia means “abnormal movement.” Tardive dyskinesia is characterized by involuntary, repetitive movements of the extremities.

Unfortunately, symptoms of tardive dyskinesia are rarely reversible and there is no known treatment. However, in some patients, symptoms may lessen or resolve after Reglan treatment is stopped. Those at greatest risk include the elderly, especially older women, and people who have been taking Reglan for a long time.

Reglan Tardive Dyskinesia Lawsuit

The Reglan lawyers at our law firm are currently reviewing potential Reglan lawsuits on behalf of individuals who have experienced symptoms of a movement disorder. These symptoms may include:

  • involuntary, repetitive movements of the extremities
  • lip smacking
  • grimacing
  • tongue protrusion
  • rapid eye movements or blinking
  • puckering and pursing of the lips
  • impaired movement of the fingers

Free Reglan Lawsuit Consultation

If you or a loved one has experienced serious Reglan side effects, the Reglan attorneys at our law firm would be happy to answer your legal questions and address your concerns. The Reglan attorneys at our law firm can also inform you of your legal rights and options, as well as your chances at succeeding in a Reglan lawsuit.

Contact our law firm today for a free and confidential case evaluation to determine whether you are eligible to file a Reglan lawsuit. Our attorneys operate on a contingency fee basis, which means you pay no fees or charges unless a recovery is obtained in your case.

Published November 17, 2011 by